GLP-1 Jabs Linked to Rare Side Effect That’s Worse Than ‘Ozempic Face’

Key Points:

• GLP-1 weight-loss drugs like Ozempic, Wegovy, and Mounjaro have been linked to a rare side effect of hair loss (alopecia), which may be more distressing than other known side effects such as cramping or "Ozempic face."
• A University of Pennsylvania study published in The BMJ found that GLP-1 users had a 37-68% higher risk of developing non-scarring alopecia compared to users of other diabetes drugs, though the overall risk remains low (about 7 cases per 1,000 users annually).
• Celebrities like Claudia Oshry and Sophia Umansky have publicly reported significant hair shedding after using GLP-1 medications, with rapid weight loss and nutrient deficiencies suspected as contributing factors.
• Researchers suggest that hair loss may result from disrupted hair growth cycles due to rapid weight loss or nutritional deficiencies, but the exact causes are still unclear, and the emotional impact varies among patients.
• Despite the potential for hair loss, many patients find the benefits of GLP-1 drugs outweigh the drawbacks, though awareness of this side effect is important for informed treatment decisions.